Advertisement
News
Advertisement

BSX closure device gets expanded approval in Europe

Mon, 08/27/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Boston Scientific Corp. (NYSE: BSX) in Natick has announced that its Watchman Left Atrial Appendage (LAA) closure device has an expanded indication in Europe, and now has been approved to reduce strokes in patients with atrial fibrillation (AF), and who cannot use warfarin and the newer oral blood thinners.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading